Long-term Safety of Minocycline in Patients With Gum Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Periodontitis
Interventions
DRUG

Minocycline HCl microspheres

At Baseline and all interim visits, a single unit dose of 1mg minocycline HCl (with approximately 3mg PGLA) will be professionally administered subgingivally into periodontal pockets at each site exhibiting a PD ≥ 5mm.

Trial Locations (1)

02115

Forsyth Institute, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

OraPharma

INDUSTRY

NCT00668746 - Long-term Safety of Minocycline in Patients With Gum Disease | Biotech Hunter | Biotech Hunter